Bio-Techne Corp

Bio-Techne Corp

TECH · NASDAQ
TECH · NASDAQ
73.28
USD0.570.78%

Latest News

    SeekingAlpha

    Bio-Techne jumps after Merck KGaA strikes $11.3B buyout deal

      @Investingcom
      Investingcom

      *NASDAQ ENDS AT A FRESH RECORD HIGH AHEAD OF BIG TECH EARNINGS $QQQ https://t.co/riJl12V54G

        @Investingcom
        Investingcom

        *S&P 500 AND NASDAQ END AT ALL-TIME HIGHS, VIX FALLS AS INVESTORS BRACE FOR FED DECISION AND TECH EARNINGS https://t.co/bvVFgyj7Q0

          @Investingcom
          Investingcom

          *NASDAQ ENDS AT A FRESH ALL-TIME HIGH AS TECH SHARES EXTEND RALLY https://t.co/he6n6U3rkG

            @Investingcom
            Investingcom

            *S&P 500 AND NASDAQ END AT ALL-TIME HIGHS, SCORE WEEKLY GAINS ON TECH BOOST https://t.co/PIVPKzg7ij

              @Investingcom
              Investingcom

              *CHINA PLANS TO CURB U.S. INVESTMENT IN TECH FIRMS FOLLOWING META'S TAKEOVER OF AI STARTUP MANUS 🇨🇳🇺🇸 https://t.co/k56PUNcADf

              Hold

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              72.66USD
              73.28USD

              52 Week Range

              43.20USD
              73.28USD

              Market Cap

              11.42BUSD

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US09073M1045

              CUSIP

              878377100

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              June

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              66.67

              PEG Ratio

              2.17

              Book Value

              13.79

              Dividend Share

              0.24

              Dividend Yield

              0.33%

              Earnings Share

              1.09

              Wall Street Target Price

              70.50

              EPS Estimate Current Year

              2.04

              EPS Estimate Next Year

              1.70

              EPS Estimate Current Quarter

              0.4476

              EPS Estimate Next Quarter

              0.4814

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              1,228,195,968

              Gross Profit TTM

              812,713,984

              EBITDA

              325,379,008

              Profit Margin

              14.00%

              Return On Assets TTM

              6.45%

              Return On Equity TTM

              8.33%

              Revenue Per Share TTM

              7.858

              Qtly Revenue Growth YOY

              4.60%

              Diluted Eps TTM

              1.09

              Qtly Earnings Growth YOY

              -25.00%

              Valuation

              Trailing PE

              66.67

              Forward PE

              35

              Price Sales TTM

              9.2948

              Price Book MRQ

              5.2712

              Enterprise Value Revenue

              9

              Enterprise Value EBITDA

              34

              Peers analysis

              • argenx SE
                ARGNFargenx SE

                965.00

                0.00%
              • CSL Limited
                CMXHFCSL Limited

                128.26

                0.00%
              • Be
                ONCBeOne Medicines AG

                390.94

                -2.36%
              • UCB SA ADR
                UCBJYUCB SA ADR

                151.52

                -2.31%
              • argenx NV ADR
                ARGXargenx NV ADR

                925.70

                -1.93%
              • CSL Ltd
                CSLLYCSL Ltd

                32.39

                -1.88%
              • UCB SA
                UCBJFUCB SA

                318.32

                -1.17%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                516.11

                -1.04%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                917.00

                -0.91%
              • Moderna Inc
                MRNAModerna Inc

                199.30

                -0.11%

              FAQs

              What is Bio-Techne Corp stock price today?

              What is Bio-Techne Corp stock ticker?

              Is TECH stock price going up?

              What is the analyst recommendation for TECH?

              What is TECH market cap?

              Does TECH release financial reports?

              When is TECH next earnings date?

              What were TECH Earnings for the last quarter?

              What was TECH Revenue for the last quarter?

              What was TECH Net Income for the last quarter?

              Does TECH pay dividends?

              How many employees does TECH have?

              What is TECH EBITDA?

              How to buy TECH stocks?

              Should I invest in TECH stock?